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Abstract
We have synthesized oligoarginine conjugates of selected DNA-binding agents (a bisbenzamidine, 
acridine and thiazole orange) and demonstrated that the DNA binding and cell internalization 
properties of such conjugates can be inhibited by appending a negatively charged oligoglutamic 
tail through a photolabile linker. Irradiation with UV light releases the parent octaarginine 
conjugates, thus restoring their cell internalization and biological activity. Preliminary assays using 
zebrafish embryos demonstrates the potential of this prodrug strategy for controlling in vivo 
cytotoxicity.
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The development of efficient nucleic acid binding agents and stains has been a long-standing 
research goal at the interface between chemistry and biomedicine.1 Indeed, cancer 
chemotherapy still relies largely on small DNA-binding molecules, including intercalators, 
minor groove binders and alkylating agents.2 We have recently demonstrated that the DNA 
binding affinity and selectivity of minor groove binders can be enhanced by tethering 
peptidic moieties derived from transcription factor fragments. 3 Interestingly, derivatization 
of DNA binding agents with octaarginine cell-penetrating peptides (CPPs) results in 
conjugates that display increased DNA affinity, 4 as well as more efficient cell 
internalization. 5 , 6 Unfortunately, the clinical potential of most DNA-binding agents is 
seriously compromised by their adverse side effects, and thus there is a great interest in the 
development of new derivatives with a higher site selectivity and reduced toxicity.7 One 
strategy to face this challenge consists of transforming known nucleic acid binders into non-
active prodrugs that can be selectively activated in a spatio-temporal manner. In this context, 
eugenio.vázquez@usc.es; joseluis.mascarenas@usc.es. 
Chembiochem. 2016 January 1; 17(1): 37–41. doi:10.1002/cbic.201500455.
it has been demonstrated that appropriate derivatization of DNA-binding agents with labile 
appendages allows to regulate their oligonucleotide binding properties with external inputs, 
such as light,8 or chemical stimuli.9
Herein we report a new strategy for controlling the activity of nucleic acid binders based on 
the temporary suppression of their cell internalization, as well as their nucleic acid binding 
ability. More specifically, we demonstrate that tethering a polyglutamic tail to conjugates 
between nucleic acid binders and a octaarginine sequence inhibits their cell entrance and 
leads to a considerably decrease in their citotoxicity. Importantly, when the connection is 
carried out through a semipermanent photolabile linker, it is possible to restore the active 
parent conjugates by irradiation with UV light. 10 Preliminary studies with zebrafish 
embryos demonstrates that the strategy can be applied in vivo.
As representative nucleic acid binders for designing our conjugates we chose a 
bisbenzamidine (BBA), which is known to insert in the minor groove of AT-rich sites, and 
two intercalators, acridine (ACR) and thiazole orange (TO). TO is known to display a 
significant fluorescence emission enhancement upon binding to DNA (~1000-fold) or RNA 
(~3000-fold).11 These nucleic acid-binding units are attached to the N-terminus of a 
oligocationic domain (Arg8) tethered to an oligoanionic (Glu8) tail through a photolabile 3-
amino-3-(2-nitrophenyl)-propionic acid (ANP) group (Fig. 1).12,13 The linker also includes a 
β-turn promoting sequence (Pro-Gly),14 which might favor the interaction between the Glu8
and Arg8 units, thus avoiding the formation of higher order species through intermolecular 
association. As positive controls of the photorelease reaction, we also synthesized the 
conjugates between each of the DNA binders and the octaarginine tag (BBA–R8, ACR–R8 
and TO–R8).
The core peptides R8E8 and R8 were prepared following standard Fmoc/tBu solid-phase 
synthesis protocols (Fig. 1).15 The TO and ACR units were attached to the peptide chain in 
the solid phase, and the BBA conjugates were assembled through a “click” reaction in 
solution (See the supporting information). The conjugates were purified by reverse phase 
HPLC and confirmed as the desired products by ESI-MS and MALDI.
Having at hand the desired samples, we studied the photocleavage reaction. Thus, we 
irradiated 200 μM solutions of BBA–R8E8, ACR–R8E8 and TO–R8E8 in water with a 
handheld transilluminator for 20 min (300-375 nm).16 HPLC analysis of aliquots of the 
irradiated mixtures showed the disappearance of the starting conjugates, and the formation 
of the expected photocleavage products, BBA–R8, ACR–R8 and TO–R8, as well as the E8–
nitrosoketone byproduct (see Fig. 2 for the case of the TO–R8E8, and the supporting 
information for the other conjugates).
We were then in position of studying the cellular internalization of the conjugates before and 
after irradiation. Toward this end we took advantage of the extraordinary fluorogenic 
properties of TO when binding to nucleic acids.11 Thus, HeLa cells were incubated with 10 
μM of TO–R8 in serum-free medium for 30 min at 37 °C. Analysis by fluorescence 
microscopy showed a bright intracellular red emission mainly localized in the cell nucleoli 
and cytoplasm, which is consistent with an efficient uptake of the TO conjugate and its 
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enhanced emission upon interacting with nuclear oligonucleotides as well as with 
cytoplasmic RNA. Furthermore, we could also confirm the relevance of the octaarginine tag 
for the cell entrance, since the unconjugated dye (TO) is very poorly uptaken (see the 
supporting information). Importantly, incubation of the cells with 10 μM TO–R8E8 under 
the same conditions did not show any red emission from the TO (Fig. 3, middle row, left), 
which is consistent with the expected reduced internalization of the Glu8 conjugate. 
However if the cells are irradiated for 10 min, then the resulting staining pattern is 
superimposable with that obtained from TO-R8 (Fig. 3, bottom row, left).
Once demonstrated that the attachment of a Glu8 tail to the TO-oligoarginine hybrid 
effectively inhibits its cell internalization, and that it can be recovered by irradiation with 
UV light, we studied the potential influence of this appendage in the cytotoxicity of the 
conjugates. The studies of cellular viability were carried out with HeLa 229 cells using the 
sulforhodamine B assay (see the supporting information). 17 Interestingly, while thiazole 
orange (TO) and acridine (ACR) didn’t appreciably affect the cell viability, their 
conjugation to the octaarginine unit promoted a considerable increase in the cytotoxicity, so 
that TO–R8 and ACR–R8 present IC50 values of 36 ± 1 μM and 54 ± 2 μM, respectively 
(Table 1). In agreement with previous reports,18 the octaarginine unit displays very low 
toxicity (<50% cell growth inhibition), which confirms the synergistic effect in activity 
resulting from combining the DNA intercalators with octaarginine units. More importantly, 
the R8E8 conjugates showed a drastically reduced toxicity to the point that their IC50 values 
could not be measured under the standard assay conditions (<50% CGI). Irradiation of the 
conjugates ACR–R8E8 and TO–R8E8 for 10 min (300-375 nm), before incubation, restored 
their cytotoxicity to values comparable to those of the Arg8 conjugates (IC50 63 ± 1 μM and 
44 ± 1, respectively). We also confirmed that the irradiation itself had a negligible cytotoxic 
effect (<50% CGI). In the case of the bisbenzamidine, the isolated BBA unit is already 
cytotoxic, and its derivatization with the octaarginine tail did not significantly affect its 
inherent activity (Table 1).19 However, the R8E8 conjugate presented a drastically reduced
cytotoxicity (<50% CGI), which could again be restored after irradiation (IC50 27 ± 1 μM).
Taken together, the fluorescence microscopy and cytotoxicity studies suggest that the 
activity of the R8 conjugates arises from their octaarginine-promoted internalization, and is 
most probably associated to the interaction with intracellular nucleic acids. To gain more 
information on this interaction, we performed electrophoretic mobility shift binding assays 
(EMSA) under non-denaturing conditions using double stranded oligonucleotides. 20 As 
expected, addition of increasing concentrations of BBA–R8 to a target A/T-rich dsDNA led 
to clear retarded bands consistent with the formation of the expected BBA–R8/DNA 
complexes (Fig. 4a). However, the conjugate bearing the glutamic tail (BBA–R8E8) failed to 
promote the appearance of slower-migrating bands, indicating that the Glu8 tail is strongly 
destabilizing the binding to the DNA (Fig. 4b). Incubation of the BBA–R8E8 and BBA–R8 
conjugates with an alternative DNA lacking the required A/T-rich region did not induce any 
new bands, thus confirming that the sequence selectivity of the interaction, in consonance 
with the expected behavior of the bisbenzamidine (see the supporting information).9, 21 On 
the other hand, the acridine conjugate ACR–R8 also led to clear retarded bands, which did 
not appear in the case of its Glu8 derivative (Fig. 4c and 4d, respectively). TO-R8 also 
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showed interaction with the DNA, however in this case the bands are fainter and we observe 
partial precipitation at higher concentrations, probably because of the lower intrinsic affinity 
of TO for DNA (Fig. 4e).22 In any case, it is also clear that the presence of the Glu8 unit
inhibits the interaction (Fig. 4f).
At this point we considered pertinent to run a preliminary test on the potential of the strategy 
for in vivo applications. Zebrafish are considered an excellent model organism in biomedical 
research, 23 and there are recent examples of their application in photochemical activation 
studies.24,25,26 Therefore, we decided to test the viability of our strategy to control in vivo 
toxicity analyzing the effect in the mortality of zebrafish embryos. Specifically, we 
compared toxicity effects of TO-R8, and TO-R8E8, as well as TO-R8E8 after UV 
irradiation. In the study, mortality values were corrected using the Abbott transformation 
([(X–Y)/(100–Y)] × 100).27 Control experiments on the effect of the irradiation in the fish 
embryos demonstrated that under our experimental setup, the values of mortality are under 
20 % after one min of irradiation. Consistent with the in vitro studies, TO-R8 showed the 
highest dose-dependent mortality values in vivo, with its effect increasing within a narrow 
range (from 10.8 % of mortality at 10 mg/L to 89.2 % at 30 mg/L, see the supporting 
information). Using concentrations of 40 mg/L and above, the mortality even reaches 100 %. 
Importantly, and also in agreement with our hypothesis and the in vitro results, TO-R8E8 
showed much lower mortality effects, with almost plane dose dependent response in the 
range analysed.
When the fish incubated with TO-R8E8 are irradiated for one minute with the above lamp, 
we observed a clear increase in the mortality, which must be associated with the release of 
the highly toxic TO-R8. Unfortunately, the application of short irradiation times to avoid 
UV-induced mortality limits the amount of photocleavage, and therefore we could not reach 
the mortality values of the original TO-R8. While these results showcase the limitations of 
current photolabile groups, which typically require the application of harmful short-UV light 
for photolysis,28 they also demonstrate the viability and potential of the approach for on-
demand in vivo activation. Ongoing efforts are therefore directed towards the adaptation of 
this strategy to the use of long-wavelenght photolabile linkers.29,30
Owing to the presence of a fluorogenic dye (TO) in our conjugates, we also analyzed by 
confocal microscopy the potential differences in fluorescence patterning, using anesthetized 
96 hpf embryos just immediately after the toxicity analysis. As can be observed in Fig 5 
right, there is a clear difference in the distribution of fluorescence between TO-R8 and TO-
R8E8, which is fully consistent with an efficient cellular uptaken by the first. TO-R8E8 
emits a very weak signal, mainly concentrated in the outer face of the zebrafish epidermis. 
Importantly, after one min UV irradiation of the fish treated with TO-R8E8 we observe a 
pattern that resembles that observed after incubation with TO-R8, which is fully consistent 
with partial release of the active TO-R8 species.
In summary, we have demonstrated that the incorporation of octaarginine sequences to 
different small molecule DNA binders leads to a considerable increase in their cytotoxicity, 
consistent with a synergistic promotion of both cellular uptake and nucleic acid binding. 
More important, the activity of these conjugates can be inhibited by the attachment of a Glu8 
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tail through a photolabile linker. Irradiation with UV light efficiently releases the parent 
compounds, thus restoring the cytotoxic activities. Preliminary in vivo assays using 
Zebrafish embryos are fully consistent with the in vitro results, and points towards the 
potential utility of the strategy for the development of new anticancer phototherapies.
Experimental Section
Peptides were assembled in solid phase using Fmoc/tBu strategies and the small DNA 
binding agents were prepared using known procedures. The conjugations were carried out in 
solution using cooper catalyzed azide-alkyne cycloadditions for the incorporation of the 
BBA, and amide bonds for the other. All the processes, as well as the characterization data, 
are included in the supporting information. The photolysis experiments were carried out 
using a standard UV transilluminator from UVPBioImaging, LCC (95-0222-02: 8W, λ = 
300-375 nm, 230V/50Hz); and the EMSA were carried out under standard conditions with a 
BIO-RAS Mini Protean gel system. Cytotoxicity studies were carried out with HeLa 229 
(human cervical cancer) cells using a system based on cell staining with Sulforhodamine B. 
All the details are described in the supporting information.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Structures of the different conjugates used in this study: BBA–R8E8, ACR–R8E8 and TO–
R8E8.
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Figure 2. 
Left: photocleavage reaction of the TO–R8E8 conjugate. Right: Stacked HPLCs of the UV 
promoted reaction showing the trace of the reaction crude after 20 min. Irradiation was 
performed using a transilluminator at 300-375 nm.
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Figure 3. 
Fluorescence microscopy of HeLa cells after 30 min incubation with Hoechst 3325 (3 μM) 
and TO-R8 or TO-R8E8 (both 10 μM) before and after uncaging. From left to right: red 
channel, blue channel, merge of both channels and brightfield images. Top row: 10 μM TO-
R8 after 30 min incubation. Middle row: TO-R8E8 in the same conditions. Bottom row: TO-
R8E8 irradiated with UV light for 10 min, and after 30 min of incubation. All micrographs 
taken at 400X, ISO 400 and with an exposition time of 200 ms; exc. 530-550 nm/em. 590 
nm.
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Figure 4. 
EMSA showing the binding of the BBA–R8, ACR–R8 and TO–R8 conjugates and their 
Glu8 derivatives to dsDNA. DNA concentration is 50 nM in all lanes; lanes 2-5: 50, 100, 150 
and 250 nM, of the conjugates in all gels (see the supporting information).
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Figure 5. 
Left. Mortality rates at 48 h in the in vivo toxicology analysis for Thiazole Orange (TO) 
conjugates. TO-R8E8 and TO-R8E8+UV were analysed at the same concentrations. TO-
R8E8 did not promote any relevant mortality. Right. Confocal images of toxicity test 
survival embryos at 96 hpf. TO-R8 (30 mg/L); TO-R8E8 (80 mg/L); TO-R8E8+UV (80 
mg/L).
Penas et al. Page 12
Penas et al. Page 13
Table 1
Cell growth inhibition (CGI, IC50, μM) of the small DNA binders (column 1); their octaarginine derivatives 
(column 2); and their light-sensitive Glu8 conjugates before, and after irradiation with UV light for 30 min 
(columns 3 and 4, respectively). In all cases cisplatin (IC50 = 0.79 ± 0.01 μM) was used as a positive control. 
See supporting information for experimental details.
RNA binder R8 conjugate R8E8 conjugate
No irradiation irradiated
TO < 50% CGI 36±1 < 50% CGI 44±1
ACR < 50% CGI 54±2 < 50% CGI 63±1
BBA 12±1 12±1 < 50% CGI 27±1
